XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Real estate properties:    
Land $ 793,261 $ 789,125
Buildings and improvements 6,731,677 6,621,605
Total real estate properties, gross 7,524,938 7,410,730
Accumulated depreciation (1,792,472) (1,694,901)
Total real estate properties, net 5,732,466 5,715,829
Assets of properties held for sale 0 112,437
Cash and cash equivalents 849,079 74,417
Restricted cash 59,010 [1] 16,432
Acquired real estate leases and other intangible assets, net 263,657 286,513
Other assets, net 275,640 270,796
Total assets 7,179,852 6,476,424
Liabilities and Equity    
Revolving credit facility 800,000 0
Term loan, net 0 199,049
Senior unsecured notes, net 2,803,497 2,608,189
Secured debt and finance leases, net 689,895 691,573
Liabilities of properties held for sale 0 3,525
Accrued interest 32,690 23,772
Assumed real estate lease obligations, net 63,487 67,830
Other liabilities 285,134 263,264
Total liabilities 4,674,703 3,857,202
Commitments and contingencies
Equity attributable to common shareholders:    
Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 238,374,572 and 238,268,478 shares issued and outstanding, respectively 2,384 2,383
Additional paid in capital 4,614,748 4,613,904
Cumulative net income 1,811,382 1,913,109
Cumulative distributions (4,038,325) (4,033,559)
Total equity attributable to common shareholders 2,390,189 2,495,837
Noncontrolling interest:    
Total equity attributable to noncontrolling interest 114,960 123,385
Total equity 2,505,149 2,619,222
Total liabilities and equity $ 7,179,852 $ 6,476,424
[1] As of June 30, 2021, restricted cash consists of amounts from dispositions held as collateral pursuant to the agreement governing our revolving credit facility, or our credit agreement. We may use these funds to pay for approved expenditures in accordance with our credit agreement. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties and cash held for the operations of the life science property that is owned in a joint venture arrangement in which we own a 55% equity interest.